We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01444820
Recruitment Status : Unknown
Verified October 2020 by Dr. Tamim Niazi, Sir Mortimer B. Davis - Jewish General Hospital.
Recruitment status was:  Active, not recruiting
First Posted : October 3, 2011
Last Update Posted : October 20, 2020
Sponsor:
Information provided by (Responsible Party):
Dr. Tamim Niazi, Sir Mortimer B. Davis - Jewish General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
Recruitment Status : Unknown
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : January 2023
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):